Siga Technologies (SIGA) Non-Current Deffered Revenue (2011 - 2018)

Siga Technologies (SIGA) reported Non-Current Deffered Revenue of $376.0 million for Q1 2018, little changed on a YoY basis from $376.2 million in Q1 2017, and little changed quarter-over-quarter from $377.6 million in Q4 2017.

Siga Technologies (SIGA) Non-Current Deffered Revenue (2011 - 2018) Analysis & Trends

Siga Technologies has reported Non-Current Deffered Revenue for 8 years, with the latest figure at $376.0 million in Q1 2018.

  • For the quarter ending Q1 2018, Non-Current Deffered Revenue changed 0.05% year-over-year to $376.0 million; the trailing twelve-month figure through Mar 2018 stood at $376.0 million (changed 0.05% YoY), and the FY2017 full-year result was $377.6 million, up 2.76% from the prior year.
  • Non-Current Deffered Revenue for Q1 2018 stood at $376.0 million, roughly flat from $377.6 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $377.6 million in Q4 2017, with the low at $81799.0 in Q4 2014.
  • Historically, Non-Current Deffered Revenue has averaged $268.5 million across 5 years, with a median of $271.9 million in 2016.
  • Annual changes were most pronounced in 2014 — Non-Current Deffered Revenue tumbled 99.95% — and 2015, when it surged 311955.61%.
  • Siga Technologies' Non-Current Deffered Revenue stood at $81799.0 in 2014, then surged by 311955.61% to $255.3 million in 2015, then surged by 43.97% to $367.5 million in 2016, then gained by 2.76% to $377.6 million in 2017, then retreated by 0.43% to $376.0 million in 2018.
  • The last three Non-Current Deffered Revenue figures came in at $376.0 million (Q1 2018), $377.6 million (Q4 2017), and $377.4 million (Q3 2017), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Siga Technologies 310.79 Mn 155.83 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2018 376.03 Mn
Dec 31, 2017 377.64 Mn
Sep 30, 2017 377.45 Mn
Jun 30, 2017 376.48 Mn
Mar 31, 2017 376.20 Mn
Dec 31, 2016 367.48 Mn
Sep 30, 2016 367.12 Mn
Jun 30, 2016 288.29 Mn
Mar 31, 2016 255.47 Mn
Dec 31, 2015 255.26 Mn
Sep 30, 2015 255.09 Mn
Jun 30, 2015 233.74 Mn
Mar 31, 2015 13.53 Mn
Dec 31, 2014 81,799.00
Jun 30, 2014 188.08 Mn
Mar 31, 2014 187.78 Mn
Dec 31, 2013 162.22 Mn
Sep 30, 2013 162.06 Mn
Jun 30, 2013 119.07 Mn
Mar 31, 2013 83.51 Mn